Skip to content

Effects of Insoles in Patients With Rheumatoid Arthritis: Randomized Controlled Trial.

Effects of Insoles in Patients With Rheumatoid Arthritis Through Measurement of Quality of Life and Physical Activity: Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03170947
Enrollment
96
Registered
2017-05-31
Start date
2022-01-21
Completion date
2024-12-31
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Rheumatoid arthritis, Foot, Insoles, Quality of life, Physical Activity

Brief summary

Deformity and foot pain is nearly omnipresent (90%) in rheumatoid arthritis (RA), due to the interaction between inflammation and abnormal biomechanical. These cause instability in the hindfoot, which cause deformity of the forefoot, and they cause more pressure on the plantar forefoot and more pain during daily activities. Non-pharmacological interventions (insole, footwear) have an important role, reducing pain and disability, increasing the effectiveness and improving daily activities.

Detailed description

Randomized double-blind clinical trial. Two samples of patients will be taken: the control group, which will consist of patients with rheumatoid arthritis and standardized insoles, and other group, which will consist of patients with rheumatoid arthritis and insoles made with direct adaptation technique (TAD) and patients with rheumatoid arthritis and insoles made with an scanner (CAD-CAM). The variables that the investigators will measure are: age, sex, study level, current occupation, rheumatoid arthritis evolution time, quality of life and physical function, pain and health level and general function of the foot. The investigators will use: an accelerometer, and questionnaires: Foot and Ankle Ability Measures (FAAM), Manchester foot pain and disability index (MFPDI), Medical outcomes study short form-36 (SF-36) y Foot Function Index (FFI). This study will analyze patients in the Universities of Malaga and Salford for 6 months.

Interventions

DEVICECustom Insoles

Custom insoles will make with CAD-CAM using a laser scanning and casting for its construction. All this needs the assistance of a computer. From the digital image of a positive of the limb in foam the insole will be obtained. Custom insoles make with direct adaptation technique (TAD) being of pvc resin. Once the resins are cut and with a temperature of 90º, they will be adapted to the foot (which will be protected with a sock) of the patient with the help of a vacuum. To this technique subtalar joint will be in a neutral position and metatarsal joints will be aligned.

DEVICEStandardized insoles

Standardized insoles were done by EVA material with shore of 18 and 180 kg/cm3 and manufactured, with an extension of 3/4. It was in contact with heel and plantar arch.

Sponsors

University of Malaga
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* More than 18 years of age * Early RA * To meet the criteria of American College of Rheumatology * History of bilateral subtalar and/or ankle and/or talonavicular pain * Informed consent * Normal range of motions at the ankle, subtalar, and midtarsal joints.

Exclusion criteria

* Concomitant musculoskeletal disease * Central or peripheral nervous system disease * Endocrine disorders, especially diabetes mellitus with a level of insufficient foot sensitivity * Patients with a history of orthopedic foot surgery * Those currently using foot orthoses. * Patients with foot trauma in the last 6 months previous to the study * Vascular diseases affecting the foot, active synovitis and edema. * Normal daily walking aids will be not permitted.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Active graph (bracelet) at 3 monthsone week, one month and three monthsThis outcome will be measured with an activity monitor, accelerometer

Secondary

MeasureTime frameDescription
Change from Baseline quality of life at 3 monthsone week, one month and three monthsThis outcome will be measured with a self-reported questionnaire (SF-36)
Change from Baseline foot function 3 monthsone week, one month and three monthsThis outcome will be measured with a self-reported questionnaire (foot function index)
Change from Baseline pain intensity at 3 monthsone week, one month and three monthsThis outcome will be measured with a self-reported questionnaire (Manchester foot pain and disability index)
Change from Baseline physical activity at 3 monthsone week, one month and three monthsThis outcome will be measured with a self-reported questionnaire (foot and ankle ability measure)

Countries

Spain

Contacts

Primary ContactLaura Ramos Petersen, Podiatry
lauraramos.94@hotmail.com686583936
Backup ContactGabriel Gijon Nogueron, PhD
gagijon@uma.es951952872

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026